SGMOQ — SANGAMO THERAPEUTICS, INC
—
OTC ·
Health Care ·
Biotechnology ·
CIK 1001233 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2024 | 49,412,000 | 49,412,000 | 10,631,000 | 10,672,000 | 101,635,000 | 41,918,000 | 78,865,000 |
TTM Snapshot
Revenues TTM
$98,824,000
NetIncome TTM
$21,344,000
OpCashFlow TTM
$0
Assets (Latest)
$101,635,000
Forward EPS
—
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| AMGN | AMGEN INC | $201.93B | $374.15 | — |
| GILD | GILEAD SCIENCES, INC. | $162.98B | $131.27 | — |
| ARGX | ARGENX SE | $58.44B | $939.68 | — |
| RVMD | Revolution Medicines, Inc. | $40.23B | $189.24 | — |
| BIIB | BIOGEN INC. | $31.91B | $216.12 | — |
Recent Insider Activity
No insider activity indexed for this ticker.